Serif: Analytical Development Co-Op

Company Summary:

Serif Biomedicines is a privately held, early-stage biotechnology company developing a novel approach to gene therapy that can address currently untreatable diseases.

Serif was founded by Flagship Pioneering, an innovation enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Flagship Pioneering has created over 100 groundbreaking companies over the past twenty years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Moderna (MRNA), Syros Pharmaceuticals (SYRS), Seres Therapeutics (NASDAQ:MCRB), Generate Biomedicines, Tessera Tx, Evelo Biosciences (EVLO), and Indigo Agriculture.

Position Summary:

We are searching for an experienced and enthusiastic Co-Op to join Analytical Development team. The main goal for this position is to support execution and development of test methods for characterization of novel nucleic acid therapeutics and LNP delivery vehicles. We are looking for an individual who enjoys hands-on laboratory benchwork and brings scientific rigor and intellectual curiosity to their role. This individual will have the opportunity to work in a dynamic and fast-paced entrepreneurial environment as part of a highly collaborative and rapidly growing team.

Key Responsibilities:

Work with the team to drive advancement of platform development developing methods for scalable, rigorous, and cost-effective manufacturing and quality control. Step into benchwork to execute platform goals with tenacity and agility. 

• The successful candidate will work as part of the team responsible for the development, characterization, and production of nucleic acid therapeutics
• Develop and execute analytical assays for the characterization and release of nucleic acid cargo and LNP drug product
• Analyze, summarize, and present experimental results to team members and management
• Explore new technologies and methods to optimize current processes in fast-paced research environment
• Maintain up-to-date records and communicate results to team members in written technical reports and oral presentations
• Participate in experimental design and troubleshooting efforts
• Interpret and summarize experimental data and maintain excellent laboratory notebooks

Qualifications:

• Current student enrolled in a Bachelors or Master’s program in Chemical Engineering, Biochemical Engineering, Bioengineering, Biomolecular Engineering, Chemistry, Biochemistry, Biomedical Engineering, Biophysics, Biotechnology, Molecular Biology, or a related field
• GPA of 3.5 on a 4 scale or equivalent
• Attention to detail, ability to multi-task, and troubleshoot
• Strong written and verbal communication skills
• Excellent record keeping and data management skills
• Excellent organization skills, approaching tasks with efficiency
• Ability to analyze, summarize, and communicate scientific data
• Ability to work independently and collaborate with other members of the team
• Laboratory skills applicable to development and execution of analytical assays
• Preferred: Hands-on experience with plate-based (ELISA, qPCR, fluorescence assays) or separation (CE, HPLC) techniques
• The ideal candidate is adaptable, enthusiastic about new challenges, has an innate curiosity, and a passion for learning

More About Flagship Pioneering

We are creative optimists and we would love for you to consider joining our team!  See all our open opportunities across Flagship Pioneering’s Ecosystem!

Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $34 billion in aggregate value. To date, Flagship is backed by more than $4.4 billion of aggregate capital commitments, of which over $1.9 billion has been deployed toward the founding and growth of its pioneering companies alongside more than $10 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 41 transformative companies, including:  Axcella Health (NASDAQ: AXLA), Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO),  Foghorn Therapeutics, Indigo Ag, Kaleido Biosciences (NASDAQ: KLDO), Moderna (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Sana Biotechnology, Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).

We believe pioneering is best done by teams, and that it is a process that can be taught, learned, and replicated.  Learn more about our Company Creation Model.

Can Breakthrough Innovations Be Made Systematically? A Conversation With Noubar Afeyan, Flagship Pioneering’s CEO.

Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.

Recruitment & Staffing Agencies:  Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates.  The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team.   Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.

The pay range for this role is $25 - $35 per hour. This role is a short-term engagement that is not eligible for health and welfare benefits. Retirement benefits may be available after completing a set number of hours. Compensation and benefits information is based on Serif Biomedicines's good faith estimate as of the date of publication and may be modified in the future.